Forte Biosciences, Inc. Profile Avatar - Palmy Investing

Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas,…

Biotechnology
US, Dallas [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Forte Biosciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Forte Biosciences, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Forte Biosciences, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of FBRX's Analysis
CIK: 1419041 CUSIP: 34962G109 ISIN: US34962G1094 LEI: - UEI: -
Secondary Listings
FBRX has no secondary listings inside our databases.